This case study follows one patient from early cognitive symptoms through diagnosis and post-treatment monitoring, showing how plasma p-tau217 testing guides anti-amyloid therapy decisions in APAC clinical settings. Presented by Prof. Atsushi Iwata (Tokyo Metropolitan Institute for Geriatrics and Gerontology), it helps clinicians interpret biomarker results and plan patient management with confidence.
Videos